Suppr超能文献

丝裂霉素C在内切术后前尿道狭窄中的疗效:一项系统评价和荟萃分析。

Efficacy of mitomycin-C on anterior urethral stricture after internal urethrotomy: A systematic review and meta-analysis.

作者信息

Irdam Gampo Alam, Wahyudi Irfan, Andy Andy

机构信息

Department of Urology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, DKI Jakarta, 10430, Indonesia.

出版信息

F1000Res. 2019 Aug 8;8:1390. doi: 10.12688/f1000research.19704.3. eCollection 2019.

Abstract

Mitomycin-C is a potent agent that plays an important role in tissue healing and scar formation. This study aims to investigate the efficacy of Mitomycin-C in treating anterior urethral stricture after internal urethrotomy. Studies evaluating efficacy of mitomycin-c for anterior urethral stricture post urethrotomy were searched using Pubmed, Scopus, Sciencedirect, MEDLINE, and Cochrane Reviews as directory databases. The search was done in March 15th 2020. Terms being used in the searching process were "mitomycin-c" or "mitomycin", "urethral stricture", "urethral stenosis", "internal urethrotomy", "optical urethrotomy" and its synonyms. Every study with the design of retrospective or prospective clinical study being done in human subject was included. Study appraisal conducted in accordance to Oxford University Center for Evidence-Based Medicine. The conclusion of each study was summarized and the calculation of random effects from every study was conducted in meta-analysis. Random effects model is chosen because small number of studies and quite different. Three studies involving 311patients were included in this review, all of them reported less recurrence of in patients treated with mitomycin-c post urethrotomy (p<0.001). Risk ratio of all studies was 0.41 with 95% confidence interval (0.25-0.68).   Mitomycin-C has the potential of efficacy in treating anterior urethral stricture post internal urethrotomy. Relatively few numbers of studies may impact in the strength of this review and further studies need to be done.

摘要

丝裂霉素-C是一种强效药物,在组织愈合和瘢痕形成中起重要作用。本研究旨在探讨丝裂霉素-C治疗尿道内切开术后前尿道狭窄的疗效。使用PubMed、Scopus、ScienceDirect、MEDLINE和Cochrane综述作为目录数据库,检索评估丝裂霉素-C治疗尿道切开术后前尿道狭窄疗效的研究。检索于2020年3月15日进行。检索过程中使用的术语为“丝裂霉素-C”或“丝裂霉素”、“尿道狭窄”、“尿道狭窄症”、“尿道内切开术”、“光学尿道切开术”及其同义词。纳入每项针对人类受试者进行的回顾性或前瞻性临床研究设计的研究。根据牛津大学循证医学中心进行研究评估。总结每项研究的结论,并在荟萃分析中对每项研究的随机效应进行计算。选择随机效应模型是因为研究数量少且差异较大。本综述纳入了三项涉及311例患者的研究,所有研究均报告尿道切开术后接受丝裂霉素-C治疗的患者复发率较低(p<0.001)。所有研究的风险比为0.41,95%置信区间为(0.25-0.68)。丝裂霉素-C在治疗尿道内切开术后前尿道狭窄方面具有潜在疗效。相对较少的研究数量可能会影响本综述的力度,需要进行进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c978/9843276/ee85d6ccc746/f1000research-8-28494-g0000.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验